Birchview Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.3M | Sell |
|
|||||
|
2025
Q2 | $15M | Sell |
|
|||||
|
2025
Q1 | $41.8M | Buy |
|
|||||
|
2024
Q4 | $38.8M | Sell |
|
|||||
|
2024
Q3 | $35.5M | Sell |
|
|||||
|
2024
Q2 | $28.6M | Sell |
|
|||||
|
2024
Q1 | $38.2M | Buy |
|
|||||
|
2023
Q4 | $36M | Sell |
|
|||||
|
2023
Q3 | $41.6M | Sell |
|
|||||
|
2023
Q2 | $46.6M | Hold |
|
|||||
|
2023
Q1 | $50.5M | Buy |
|
|||||
|
2022
Q4 | $52.4M | Hold |
|
|||||
|
2022
Q3 | $51.7M | Hold |
|
|||||
|
2022
Q2 | $56M | Sell |
|
|||||
|
2022
Q1 | $55.1M | Sell |
|
|||||
|
2021
Q4 | $47.8M | Sell |
|
|||||
|
2021
Q3 | $47.1M | Hold |
|
|||||
|
2021
Q2 | $53.2M | Buy |
|
|||||
|
2021
Q1 | $50.1M | Sell |
|
|||||
|
2020
Q4 | $49.3M | Hold |
|
|||||
|
2020
Q3 | $47.9M | Buy |
|
|||||
|
2020
Q2 | $46.6M | Buy |
|
|||||
|
2020
Q1 | $43.8M | Buy |
|
|||||
|
2019
Q4 | $50M | Buy |
|
|||||
|
2019
Q3 | $2.38M | Buy |
|
|||||
|
2019
Q2 | $2M | Buy |
|
|||||
|
2019
Q1 | $954K | Buy |
|